Adkins Katherine

CLO Katherine Adkins sold 36,878 shares of AFRM at $95.00 for $3,503,410.00 on 2025-08-29; post-sale holdings: 122,553 shares.

Katherine Adkins, Chief Legal Officer, executed a sale of 36,878 shares at $95.00, reducing her holdings by 23.1% and generating $3,503,410.00 in proceeds. The transaction price of $95.00 sits above the current price of $85.31 but within the 52-week range of $35.75–$88.46. This sale follows an active selling pattern at AFRM: Adkins executed five prior trades at this ticker in the past year, including three additional sales in August and July 2025. Across her same-ticker history at AFRM, prior 90-day outcomes on sells show a 0 of 2 well-timed rate—meaning her recent sales at this company have not preceded declines; in fact, the one measurable 90-day outcome (the 2024-11-11 sale) returned +36.6%, indicating the stock rose after that sale. The company shows solid fundamentals with $783.1M in latest quarterly revenue, +38.8% annual revenue growth, and a P/E of 9.95, though net income remains modest at $2.8M. Given the frequency of her recent transactions and the pattern of prior sales that did not precede weakness, this transaction merits attention but does not signal an obvious structural concern about the company's prospects.

Chief Legal Officer Adkins sells 60,596 shares (34.8% of pre-transaction holdings) at $75.02 blended average for $4.5M

Adkins Katherine, Chief Legal Officer, executed 2 separate sales on consecutive days totaling 60.6K shares for $4,545,885.34, reducing her holdings by 34.8% from 174.0K to 113.4K shares. The blended average price of $75.02 was near the current price of $74.86 and represents transactions near the 52-week high of $80.98 (-7.6% currently). At AFRM specifically, Adkins' prior 4 measurable sales (2024-09-16 through 2024-11-11) all posted positive 90-day returns averaging +53.1%, indicating her prior AFRM sales preceded stock appreciation rather than declines; the timing pattern shows 0 of 4 prior sales were well-timed at the 90-day mark. AFRM remains unprofitable on a full-year basis despite +46.3% annual revenue growth and recent 90-day stock appreciation of +45.2%, creating a backdrop where a substantial insider reduction of stake warrants investor attention to the insider's forward assessment.

CLO Katherine Adkins sold 57.1K AFRM shares at $70.27 ($4.0M); stock up 12.6% in 30d, now -14.7% from 52wk high

Katherine Adkins (CLO) sold 57,102 shares at $70.27, reducing her holdings from 169,569 to 112,467 shares (-33.7%). At her prior four AFRM sales, the stock subsequently rose all four times over 90 days (100% positive returns: 36.6%, 57.5%, 61.9%, 57.1%), meaning none of those sales preceded declines — a timing pattern that offers no signal of prescience. The company grew revenue 46.3% annually and posted positive net income of $2,804,000 in the latest quarter, though full-year net income was negative, creating mixed fundamental signals. The sale occurred when the stock was +12.6% over 30 days but -14.7% from its 52-week high of $80.98, suggesting execution within a period of strength rather than ahead of deterioration.

Adkins (CLO) sold 200,000 AFRM shares at $55.05 (11.0M), reducing stake 68.1% to 93.5K shares.

Chief Legal Officer Katherine Adkins divested a substantial 200,000 shares of Affirm Holdings, reducing her holdings by 68.1% in a single transaction, though she retained a meaningful position of 93.5K shares post-sale. The $11.0M sale occurred near the 52-week high ($57.59), with the stock trading 4.8% below its peak and up 93.2% over the prior 90 days, suggesting the sale may have coincided with elevated valuation following a pronounced recent rally. Affirm remains unprofitable despite strong revenue growth of 46.3%, with the company posting a $-100.2M net loss in the latest quarter; the substantial reduction in a CLO's holdings warrants scrutiny of potential regulatory or compliance considerations, though the sale pattern at this ticker shows mixed timing outcomes (two prior September 2024 sells were poorly timed, while an earlier September 2024 sell succeeded).

CLO Adkins sold 135,000 shares at $45.00 over 3 days for $6,075,068.81, reducing stake by 59.6%.

Katherine Adkins, Chief Legal Officer at Affirm Holdings, executed 3 separate sales totaling 135,000 shares (135.0K shares) for $6,075,068.81 ($6.1M) at $45.00 on September 16–18, 2024. This represents a -59.6% reduction in her holdings, from 226,499 shares to 91,499 shares. The transaction occurred during a period of strong price momentum—Affirm's stock is +46.0% over the prior 30 days and +46.9% over 90 days—at a blended price ($45.00) just -13.8% from the 52-week high ($51.39). Notably, the company generated $576.2M in quarterly revenue with +46.3% annual growth but remains unprofitable, with full-year net income of $-133.9M. The scale and pace of this divestiture—eliminating more than half her position in three consecutive days at elevated valuations—stands out relative to the company's underlying profitability challenges.